Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Access before approval--a right to take experimental drugs?

× No keyword cloud information.

6 in total

1. Compassionate use of interventions: results of a European Clinical Research Infrastructures Network (ECRIN) survey of ten European countries.

Authors: Kate Whitfield; Karl-Heinz Huemer; Diana Winter; Steffen Thirstrup; Christian Libersa; Béatrice Barraud; Christine Kubiak; Lea Stankovski; Xina Grählert; Gabriele Dreier; Sebastian Geismann; Wolfgang Kuchinke; Anke Strenge-Hesse; Zsuza Temesvari; Gyorgy Blasko; Gabriella Kardos; Timothy O'Brien; Margaret Cooney; Siobhan Gaynor; Arrigo Schieppati; Mariantonia Serrano; Fernando de Andres; Nuria Sanz; Raquel Hernández; Germán Kreis; Charlotte Asker-Hagelberg; Hanna Johansson; Adeeba Asghar; Jean-Marc Husson; Jacques Demotes; Christian Gluud
Journal: Trials Date: 2010-11-12 Impact factor: 2.279

6. Going "social" to access experimental and potentially life-saving treatment: an assessment of the policy and online patient advocacy environment for expanded access.

Authors: Tim K Mackey; Virginia J Schoenfeld
Journal: BMC Med Date: 2016-02-02 Impact factor: 8.775

6 in total

Access before approval--a right to take experimental drugs?

1. Compassionate use of interventions: results of a European Clinical Research Infrastructures Network (ECRIN) survey of ten European countries.

2. Access to experimental medicines for TB: ethical and human rights considerations.

3. Why are promising new drugs for dying patients still out of reach?

4. Uncertainty and equipoise: at interplay between epistemology, decision making and ethics.

5. When is it rational to participate in a clinical trial? A game theory approach incorporating trust, regret and guilt.

6. Going "social" to access experimental and potentially life-saving treatment: an assessment of the policy and online patient advocacy environment for expanded access.